Chapter 12. Using Economic Evaluation to Inform Health Policy and Reimbursement: Making it Happen and Making it Sustainable

  1. Nick Freemantle1 and
  2. Suzanne Hill2
  1. Andrew Mitchell

Published Online: 5 NOV 2007

DOI: 10.1002/9780470994719.ch12

Evaluating Pharmaceuticals for Health Policy and Reimbursement

Evaluating Pharmaceuticals for Health Policy and Reimbursement

How to Cite

Mitchell, A. (2004) Using Economic Evaluation to Inform Health Policy and Reimbursement: Making it Happen and Making it Sustainable, in Evaluating Pharmaceuticals for Health Policy and Reimbursement (eds N. Freemantle and S. Hill), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470994719.ch12

Editor Information

  1. 1

    Department of Primary Care and General Practice, University of Birmingham,Birmingham,UK

  2. 2

    Faculty of Health,University of Newcastle,Newcastle, Australia

Publication History

  1. Published Online: 5 NOV 2007
  2. Published Print: 1 AUG 2004

ISBN Information

Print ISBN: 9780727917843

Online ISBN: 9780470994719

SEARCH

Keywords:

  • health policy;
  • health reimbursement;
  • economic evaluation;
  • pharmaceutical products;
  • cost-effectiveness ratio

Summary

This chapter contains sections titled:

  • Introduction

  • Making it happen

  • High level steps

  • High level step 1: link to policy

  • High level step 2: establish authority and infrastructure

  • High level step 3: define framework and scope and issue guidelines

  • The technical level

  • Technical issue 1: maximising scientific credibility and grappling with uncertainty

  • Technical issue 2: applying the evidence

  • Technical issue 3: extrapolating the evidence

  • Technical issue 4: internal consistency across claims and supporting information

  • Technical issue 5: “oscaling up” to the overall impact on costs and outcomes across the population

  • Making it sustainable

  • Consolidation step 1: making defensible efficiency decisions

  • Consolidation step 2: identifying the influence of other relevant factors

  • Consolidation step 3: promoting accountability and transparency

  • Consolidation step 4: establishing a culture of continuous improvement

  • Consolidation step 5: collaborating internationally with similar decision makers

  • Conclusion

  • References